MedTrace Logo

Analysis of the Nasal Mucosal Immune Response in HIV Infection

NCT03920709 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2022-09-08

No results posted yet for this study

Summary

The principal objective is to define and compare the viral reservoir, mucosal immune responses and the microbiota of different HIV infection stages; viremic, aviremic (under treatment), natural elite controllers; The secondary objective is to compare the mucosal immune response and microbiota of HIV patients with the healthy control population of Milieu Interieur;

Conditions

  • HIV Infections

Interventions

OTHER

Blood sample and Nasal swabs (right an left) samples

Nasal swabs (right and left) will be performed (FLOQSwabTM) Blood samples of 20 mL EDTA will be taken in addition to the current care report

Sponsors & Collaborators

  • Pasteur Institute of Paris

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Cécile Goujard, Pr · AP-HP Hôpital Bicêtre

Eligibility

Min Age
20 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-02
Primary Completion
2023-06-01
Completion
2023-06-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03920709 on ClinicalTrials.gov